Fintel reports that on December 15, 2025, Wells Fargo maintained coverage of CareDx (NasdaqGM:CDNA) with a Equal-Weight ...

In a unanimous decision last month, the Supreme Court ruled that naturally occurring genes are not patentable. But, said the Court, cDNA, a man-made copy of the genetic messenger in cells, is ...

AMD gave us a glimpse of its future this week, divulging new information about its Radeon and Ryzen roadmaps during the company’s Financial Analyst Day. Lots of new information was disseminated, but ...

AMD's next-gen CDNA 3 architecture will be the first exascale APU design, packing both CPU and GPU chiplets on the same package. AMD has promised an insane 5x or higher (AI) performance-per-watt ...

Multiple intravenous injections of a cDNA library, derived from human melanoma cell lines and expressed using the highly immunogenic vector vesicular stomatitis virus (VSV), cured mice with ...

In addition to the Instinct MI325X AI Accelerator, AMD also updated its AMD Instinct roadmap and previewed the upcoming Instinct MI355X AI Accelerator at its Advance AI event held earlier. Based on ...

We recently compiled a list of the 10 Best Organ Transplant and Diagnosis Stocks To Buy Now. In this article, we are going to take a look at where CareDx, Inc (NASDAQ:CDNA) stands against the other ...

Most attempts to identify and isolate a novel cDNA result in the acquisition of clones that represent only a part of the mRNA's complete sequence. The ever-growing collections of sequenced genomes and ...

Back in 2020, AMD announced it was splitting its post-GCN architecture into RDNA for gaming, with CDNA for its data center GPUs, with CDNA later being the architecture of its Radeon Instinct AI ...

CDNA has resolved corporate instability and insurance issues, showing potential for sustainable growth with innovative transplant testing services like AlloSure, AlloMap, and HeartCare. CDNA's ...

CareDx (CDNA) closed the last trading session at $23.10, gaining 1.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...